Induction chemotherapy followed by concurrent radio-chemotherapy versus concurrent radio-chemotherapy alone as treatment of locally advanced squamous cell …

W Budach, E Bölke, K Kammers, PA Gerber… - Radiotherapy and …, 2016 - Elsevier
Background Induction chemotherapy with docetaxel, cisplatin and 5 FU (TPF) before
radiotherapy (RT) or radio-chemotherapy (RT-CHX) has been shown to improve overall …

[HTML][HTML] Induction chemotherapy with concurrent chemoradiotherapy versus concurrent chemoradiotherapy for locally advanced squamous cell carcinoma of head …

L Zhang, N Jiang, Y Shi, S Li, P Wang, Y Zhao - Scientific reports, 2015 - nature.com
Concurrent chemoradiotherapy (CCRT) has been considered to be the standard of care for
locally advanced squamous cell carcinoma of head and neck (LA-SCCHN). Whether …

[HTML][HTML] The effect of induction chemotherapy using docetaxel, cisplatin, and fluorouracil on survival in locally advanced head and neck squamous cell carcinoma: a …

R Kim, S Hahn, J Shin, CY Ock, M Kim… - … : Official Journal of …, 2016 - synapse.koreamed.org
Purpose The purpose of this study was to compare the survival of patients with locally
advanced head and neck squamous cell carcinoma (LA-HNSCC) undergoing concurrent …

[HTML][HTML] A randomized phase III trial comparing induction chemotherapy followed by chemoradiotherapy versus chemoradiotherapy alone as treatment of …

R Hitt, JJ Grau, A López-Pousa, A Berrocal… - Annals of …, 2014 - Elsevier
Background Concurrent chemoradiotherapy (CCRT) is the standard treatment for patients
with unresectable, nonmetastatic locoregionally advanced squamous-cell carcinoma of the …

Final results of a randomized phase III trial comparing induction chemotherapy with cisplatin/5-FU or docetaxel/cisplatin/5-FU follow by chemoradiotherapy (CRT) …

R Hitt, JJ Grau, A Lopez-Pousa, A Berrocal… - Journal of Clinical …, 2009 - ascopubs.org
6009 Background: Induction chemotherapy (IC) with TPF isa standard regimen for patients
(pts) with locally advanced head and neck squamous cell carcinoma (N Engl J Med. 2007; …

DeCIDE: A phase III randomized trial of docetaxel (D), cisplatin (P), 5-fluorouracil (F)(TPF) induction chemotherapy (IC) in patients with N2/N3 locally advanced …

EEW Cohen, T Karrison, M Kocherginsky, CH Huang… - 2012 - ascopubs.org
5500 Background: IC is associated with lower distant failure (DF) rates in SCCHN but an
improvement in overall survival (OS) has not been validated. The goal of this trial was to …

[HTML][HTML] Induction chemotherapy in locally advanced squamous cell carcinoma of the head and neck: role, controversy, and future directions

RI Haddad, M Posner, R Hitt, EEW Cohen, J Schulten… - Annals of …, 2018 - Elsevier
Background The value of induction chemotherapy (ICT) remains under investigation despite
decades of research. New advancements in the field, specifically regarding the induction …

Phase III randomized trial of induction chemotherapy in patients with N2 or N3 locally advanced head and neck cancer

EEW Cohen, TG Karrison, M Kocherginsky… - Journal of clinical …, 2014 - ascopubs.org
Purpose Induction chemotherapy (IC) before radiotherapy lowers distant failure (DF) rates in
locally advanced squamous cell carcinoma of the head and neck (SCCHN). The goal of this …

[HTML][HTML] Concomitant chemoradiotherapy versus induction docetaxel, cisplatin and 5 fluorouracil (TPF) followed by concomitant chemoradiotherapy in locally …

A Paccagnella, MG Ghi, L Loreggian, A Buffoli… - Annals of oncology, 2010 - Elsevier
Abstract Background Concomitant chemoradiotherapy (CT/RT) is the standard treatment of
locally advanced squamous cell carcinoma of the head and neck (SCCHN). We evaluated …

Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced …

R Haddad, A O'Neill, G Rabinowits, R Tishler… - The Lancet …, 2013 - thelancet.com
Background The relative efficacy of the addition of induction chemotherapy to
chemoradiotherapy compared with chemoradiotherapy alone for patients with head and …